Evidence map›Paper›PMID 34383776›Full record

ArticlePloS one2021

Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.

Mwayi Kachapila, Adesoji O Ademuyiwa, Bruce M Biccard, Dhruva N Ghosh, James Glasbey, Mark Monahan, Rachel Moore, Dion G Morton, Raymond Oppong, Rupert Pearse and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Mwayi KachapilaNational Institute for Health Research Global Health Research Unit on Global Surgery, Institute of Translational Medicine, University of Birmingham, Birmingham, England, United Kingdom.ORCID https://orcid.org/0000-0002-8427-5612
Adesoji O AdemuyiwaPaediatric Surgery Unit, Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
Bruce M BiccardDepartment of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
Dhruva N GhoshIndia Hub National Institute for Health Research Global Health Research Unit on Global Surgery, Ludhiana, India.
James GlasbeyNational Institute for Health Research Global Health Research Unit on Global Surgery, Institute of Translational Medicine, University of Birmingham, Birmingham, England, United Kingdom.
Mark MonahanNational Institute for Health Research Global Health Research Unit on Global Surgery, Institute of Translational Medicine, University of Birmingham, Birmingham, England, United Kingdom.
Rachel MooreDepartment of Surgery, University of the Witwatersrand, Johannesburg, South Africa.
Dion G MortonNational Institute for Health Research Global Health Research Unit on Global Surgery, Institute of Translational Medicine, University of Birmingham, Birmingham, England, United Kingdom.
Raymond OppongHealth Economics Unit, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, England, United Kingdom.
Rupert PearseBarts and The London School of Medicine and Dentistry, Queen Mary University of London, London, England, United Kingdom.
Tracy E RobertsNational Institute for Health Research Global Health Research Unit on Global Surgery, Institute of Translational Medicine, University of Birmingham, Birmingham, England, United Kingdom.
NIHR Global Health Research Unit on Global Surgery
ASOS Investigators
STARSurg Collaborative
National Institute for Health Research · GBChristian Medical College, Vellore · INQueen Mary University of London · GBUniversity of Birmingham · GBUniversity of Cape Town · ZAUniversity of Lagos · NGUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPneumonia is a common and severe complication of abdominal surgery, it is associated with increased length of hospital stay, healthcare costs, and mortality. Further, pulmonary complication rates have risen during the SARS-CoV-2 pandemic. This study explored the potential cost-effectiveness of administering preoperative chlorhexidine mouthwash versus no-mouthwash at reducing postoperative pneumonia among abdominal surgery patients.

methodsA decision analytic model taking the South African healthcare provider perspective was constructed to compare costs and benefits of mouthwash versus no-mouthwash-surgery at 30 days after abdominal surgery. We assumed two scenarios: (i) the absence of COVID-19; (ii) the presence of COVID-19. Input parameters were collected from published literature including prospective cohort studies and expert opinion. Effectiveness was measured as proportion of pneumonia patients. Deterministic and probabilistic sensitivity analyses were performed to assess the impact of parameter uncertainties. The results of the probabilistic sensitivity analysis were presented using cost-effectiveness planes and cost-effectiveness acceptability curves.

resultsIn the absence of COVID-19, mouthwash had lower average costs compared to no-mouthwash-surgery, $3,675 (R 63,770) versus $3,958 (R 68,683), and lower proportion of pneumonia patients, 0.029 versus 0.042 (dominance of mouthwash intervention). In the presence of COVID-19, the increase in pneumonia rate due to COVID-19, made mouthwash more dominant as it was more beneficial to reduce pneumonia patients through administering mouthwash. The cost-effectiveness acceptability curves shown that mouthwash surgery is likely to be cost-effective between $0 (R0) and $15,000 (R 260,220) willingness to pay thresholds.

conclusionsBoth the absence and presence of SARS-CoV-2, mouthwash is likely to be cost saving intervention for reducing pneumonia after abdominal surgery. However, the available evidence for the effectiveness of mouthwash was extrapolated from cardiac surgery; there is now an urgent need for a robust clinical trial on the intervention on non-cardiac surgery.

Indexed as

Models, TheoreticalAbdomenChlorhexidineCost-Benefit AnalysisCOVID-19HumansMouthwashesPandemicsPneumoniaPostoperative ComplicationsPreoperative CareProspective StudiesSouth AfricaChlorhexidineMouthwashes

Identifiers

PMID34383776
PMCPMC8360544
OpenAlexW3192332439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.